A phase I/IIa study of the safety and efficacy of radium-223 chloride (Ra-223) with docetaxel (D) for castration-resistant prostate cancer (CRPC) patients with bone metastases Meeting Abstract

  


Authors: Morris, M. J.; Hammers, H. J.; Sweeney, C.; Bloma, M.; Aksnes, A. K.; O'Bryan-Tear, C. G.; Carrasquillo, J. A.
Abstract Title: A phase I/IIa study of the safety and efficacy of radium-223 chloride (Ra-223) with docetaxel (D) for castration-resistant prostate cancer (CRPC) patients with bone metastases
Meeting Title: 48th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 30
Issue: 15 Suppl.
Meeting Dates: 2012 Jun 1-5
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2012-05-20
Language: English
ACCESSION: WOS:000318009803155
PROVIDER: wos
DOI: 10.1200/jco.2012.30.15_suppl.TPS4694
Notes: Meeting Abstract: TPS4694 -- Source: Wos
Altmetric
What is Altmetric?
Citation Impact
What is Dimensions Citation Badge?
BMJ Impact Analytics
MSK Authors
  1. Michael Morris
    577 Morris
  2. Jorge Carrasquillo
    140 Carrasquillo
Related MSK Work